10x Genomics, Inc. (TXG)

NMS – Цена в реальном времени. Валюта: USD

20.92

+0.42 (2.05%)

При закрытии: May 12, 2026, 4:00 PM EDT

09.05.2026

Torex Gold Resources Inc. (TXG:CA) Q1 2026 Earnings Call Transcript

09.05.2026

10x Genomics Q1 Earnings Call Highlights

10x Genomics NASDAQ: TXG reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument platform that management described as the most significant product introduction in the company's history.

08.05.2026

10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up

TXG beats Q1 estimates as consumables growth, margin expansion and lower operating costs narrow losses year over year.

08.05.2026

10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript

07.05.2026

10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.36 per share a year ago.

07.05.2026

10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

07.05.2026

10x Genomics Reports First Quarter 2026 Financial Results

PLEASANTON, Calif., May 7, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2026.

Видео

No Data

There is no data to display

Пресс-релизы

07.05.2026

10x Genomics Reports First Quarter 2026 Financial Results

29.04.2026

10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference

PLEASANTON, Calif., April 29, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, at 5:00 p.m.

23.04.2026

LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor

SAN CARLOS, Calif.--(BUSINESS WIRE)--LiquidCell Dx, a precision diagnostics company building a blood-based platform for tumor microenvironment profiling, today announced the appointment of Mirna Jarosz as Chief Executive Officer and Vincent A. Miller, MD, as Senior Strategic Advisor. The appointments add operating, commercialization and clinical leadership as the company advances its platform and prepares for the next stage of growth. Comprehensive genomic profiling changed oncology by making t.

19.04.2026

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at Scale Debuts at AACR Annual Meeting 2026 with Data from Leading Research Institutions, Including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research Institute (DKFZ) PLEASANTON, Calif., April 18, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell sensitivity at unprecedented scale.

10x Genomics, Inc. (TXG)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

10x Genomics, Inc. (TXG)

Torex Gold Resources Inc. (TXG:CA) Q1 2026 Earnings Call Transcript

10x Genomics Q1 Earnings Call Highlights

10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript

10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates

10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

10x Genomics Reports First Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

10x Genomics Reports First Quarter 2026 Financial Results

10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference

LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Torex Gold Resources Inc. (TXG:CA) Q1 2026 Earnings Call Transcript

10x Genomics Q1 Earnings Call Highlights

10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript

10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates

10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

10x Genomics Reports First Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

10x Genomics Reports First Quarter 2026 Financial Results

10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference

LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Search stocks

10x Genomics, Inc. (TXG)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

10x Genomics, Inc. (TXG)

Torex Gold Resources Inc. (TXG:CA) Q1 2026 Earnings Call Transcript

10x Genomics Q1 Earnings Call Highlights

10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript

10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates

10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

10x Genomics Reports First Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

10x Genomics Reports First Quarter 2026 Financial Results

10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference

LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Torex Gold Resources Inc. (TXG:CA) Q1 2026 Earnings Call Transcript

10x Genomics Q1 Earnings Call Highlights

10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript

10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates

10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

10x Genomics Reports First Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

10x Genomics Reports First Quarter 2026 Financial Results

10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference

LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood